Capricor Therapeutics CAPR Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$33.94M-39.2% | -$30.17M-324% | -$24.57M-95.7% | -$25.91M-136% | -$24.39M-149% | ||
| $534.67K+31.9% | $502.59K+33.8% | $494.73K+37.0% | $486.28K+36.2% | $405.45K+22.3% | ||
| $5.92M+8.0% | $3.84M+67.3% | $4M+94.9% | $3.65M+69.4% | $5.48M+67.9% | ||
| -$3.08M-334% | $2.17M+30.6% | $971.65K+169% | $1.53M+2,042% | $1.32M+83,135% | ||
| -$979.78K-1,666% | $3.33M+227% | $966.33K+314% | -$142.77K+39.8% | -$55.47K-143% | ||
| $6.59K+104% | —— | —— | —— | -$150.67K— | ||
| -$29.25M-355% | -$23.57M-59.3% | -$19.69M-69.1% | -$20.12M-63.7% | -$6.43M-407% | ||
| $5.12M+472% | $1.66M+241% | $55.84K+511% | $287.74K+377% | $896.01K+47.2% | ||
| -$154.64M-747% | $43.09M+135% | $15.95M+696% | $14.55M-1.0% | $23.89M+351% | ||
| $1.47M+2,821% | $236.96M+193% | $6.95K-100.0% | $19.58K-99.0% | $50.35K-97.8% | ||
| $1.47M+2,821% | $248.82M+207% | $6.95K-100.0% | $19.58K-99.1% | $50.35K-97.8% | ||
| -$182.43M-1,142% | $268.34M+570% | —— | —— | $17.51M+306% | ||
| -$358.63K— | —— | —— | —— | —— | ||
| -$59.17K+99.4% | $0— | -$342— | -$325— | -$10.31M-3.1% | ||
| -$3.08M-334% | $2.17M+30.6% | $971.65K+169% | $1.53M+2,042% | $1.32M+83,135% | ||
| -$979.78K-1,666% | $3.33M+227% | $966.33K+314% | -$142.77K+39.8% | -$55.47K-143% | ||
| $641.29K+3,907% | $371.87K+2,379% | $377.28K+3,612% | -$16.84K-66.8% | -$16.84K-66.8% | ||
| $6.59K+104% | —— | —— | —— | -$150.67K— | ||
| —— | —— | —— | —— | $257.46K— | ||
| $5.92M+8.0% | $3.84M+67.3% | $4M+94.9% | $3.65M+69.4% | $5.48M+67.9% | ||
| $4.7M— | $3.46M— | $3.95M— | —— | —— | ||
| $921.75K+277% | $0-100% | $8.53K-82.9% | $130.73K+536% | $244.28K+338% | ||
| —— | $761.43K— | $761.43K— | $761.43K— | $761.43K— | ||
| -$34.38M-369% | -$25.23M-65.1% | -$19.74M-69.5% | -$20.41M-65.3% | -$7.33M-290% | ||
| -$34.38M-369% | -$25.23M-65.1% | -$19.74M-69.5% | -$20.41M-65.3% | -$7.33M-290% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where does Capricor Therapeutics's cash flow data come from?
- Every line is extracted from Capricor Therapeutics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.